Registration 333-297284
F-4/A · 2026-08-03 · 0001140361-26-030583
Terms from the governing filing for this registration; not a claim that the offering is open today.
Security
NWCLNASDAQCommon stockCurrentCIK 2131813Updated Sep 24, 2026
Loading TradingView…
NASDAQ:NWCL on TradingView ↗new cleo is an innovative nuclear energy company developing AMRs cooled by liquid lead, and facilities to produce nuclear fuel from recycled nuclear waste, with the goal of delivering abundant, competitive, low-carbon energy. The company was founded by physicist-entrepreneur Stefano Buono following the USD $3.9 billion sale of his previous venture - Nasdaq-listed nuclear medicine company Advanced Accelerator Applications - to Novartis. With, approximately USD $780 million in private funding, and more than 900 highly skilled employees across Europe and the United States, the company has built a network of over 100 industry partnerships and supports its growth through the targeted acquisition and vertical integration of key companies in the nuclear supply chain.
No coverage from other publishers is available.
Exhibit 107 CALCULATION OF FILING FEE TABLE Form F-4 (Form Type) NewCleo Ltd. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1)(2) Proposed Maximum Offering Price Per Share Maximum Aggregate Fee Rate Amount of Registration Fee(3) …
Read attachment ↗EX-99.2 10 ny20072209x2_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Consent to be Named as a Director Nominee Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement on Form F-4 of NewCleo Ltd. (the “Registrant”), and all amendment or supplements thereto (the “Registration Statement”), as a nominee to the board of directors of the Registrant, and to the filing of this consent as an exhibit to the R…
Read attachment ↗